RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)
USD 6.05
(0.0%)
USD 6.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 38.71 Million EUR | 53.96% |
| 2022 | 25.14 Million EUR | -11.14% |
| 2021 | 28.29 Million EUR | 1048.8% |
| 2020 | 2.46 Million EUR | -94.31% |
| 2019 | 43.27 Million EUR | -11.67% |
| 2018 | 48.99 Million EUR | 39.38% |
| 2017 | 35.15 Million EUR | -37.71% |
| 2016 | 56.43 Million EUR | -33.91% |
| 2015 | 85.38 Million EUR | -93.03% |
| 2014 | 1.22 Billion EUR | 1314.59% |
| 2013 | 86.64 Million EUR | -3.39% |
| 2012 | 89.68 Million EUR | -42.55% |
| 2011 | 156.11 Million EUR | 7.61% |
| 2010 | 145.06 Million EUR | 10.19% |
| 2009 | 131.65 Million EUR | 7.34% |
| 2008 | 122.64 Million EUR | 15.38% |
| 2007 | 106.29 Million EUR | 1.04% |
| 2006 | 105.2 Million EUR | 25.72% |
| 2005 | 83.68 Million EUR | 9.52% |
| 2004 | 76.4 Million EUR | -4.13% |
| 2003 | 79.69 Million EUR | 6.08% |
| 2002 | 75.12 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 9.01 Million EUR | -16.51% |
| 2024 Q1 | 10.79 Million EUR | -30.57% |
| 2023 Q4 | 15.55 Million EUR | 39.21% |
| 2023 Q3 | 11.17 Million EUR | 94.92% |
| 2023 Q2 | 5.73 Million EUR | -8.44% |
| 2023 FY | 38.71 Million EUR | 53.96% |
| 2023 Q1 | 6.25 Million EUR | -28.56% |
| 2022 Q2 | 10.51 Million EUR | 687.72% |
| 2022 Q4 | 8.76 Million EUR | 80.01% |
| 2022 Q3 | 4.86 Million EUR | -53.72% |
| 2022 Q1 | 1.33 Million EUR | -90.91% |
| 2022 FY | 25.14 Million EUR | -11.14% |
| 2021 FY | 28.29 Million EUR | 1048.8% |
| 2021 Q4 | 14.68 Million EUR | 120.96% |
| 2021 Q1 | 1.11 Million EUR | 1608.11% |
| 2021 Q3 | 6.64 Million EUR | -4.31% |
| 2021 Q2 | 6.94 Million EUR | 522.22% |
| 2020 Q2 | 218 Thousand EUR | 104.9% |
| 2020 Q4 | -74 Thousand EUR | -101.29% |
| 2020 FY | 2.46 Million EUR | -94.31% |
| 2020 Q1 | -4.44 Million EUR | -169.53% |
| 2020 Q3 | 5.75 Million EUR | 2539.45% |
| 2019 Q2 | 11.5 Million EUR | 38.16% |
| 2019 Q4 | 6.39 Million EUR | -62.47% |
| 2019 FY | 43.27 Million EUR | -11.67% |
| 2019 Q1 | 8.33 Million EUR | 147.11% |
| 2019 Q3 | 17.04 Million EUR | 48.08% |
| 2018 Q2 | 7 Million EUR | -29.91% |
| 2018 Q3 | 28.62 Million EUR | 308.78% |
| 2018 FY | 48.99 Million EUR | 39.38% |
| 2018 Q1 | 9.99 Million EUR | 4.3% |
| 2018 Q4 | 3.37 Million EUR | -88.22% |
| 2017 FY | 35.15 Million EUR | -37.71% |
| 2017 Q2 | 8.13 Million EUR | 3.54% |
| 2017 Q3 | 9.58 Million EUR | 17.93% |
| 2017 Q1 | 7.85 Million EUR | 132.68% |
| 2017 Q4 | 9.58 Million EUR | -0.08% |
| 2016 Q2 | 18.19 Million EUR | -63.55% |
| 2016 FY | 56.43 Million EUR | -33.91% |
| 2016 Q1 | 49.92 Million EUR | 138.29% |
| 2016 Q4 | -24.02 Million EUR | -294.72% |
| 2016 Q3 | 12.34 Million EUR | -32.19% |
| 2015 Q3 | 15.85 Million EUR | -3.45% |
| 2015 Q4 | 20.95 Million EUR | 32.18% |
| 2015 Q1 | 32.16 Million EUR | 1963.12% |
| 2015 Q2 | 16.41 Million EUR | -48.96% |
| 2015 FY | 85.38 Million EUR | -93.03% |
| 2014 FY | 1.22 Billion EUR | 1314.59% |
| 2014 Q4 | 1.55 Million EUR | -87.33% |
| 2014 Q3 | 12.3 Million EUR | 106.67% |
| 2014 Q2 | -184.43 Million EUR | -113.21% |
| 2014 Q1 | 1.39 Billion EUR | 6643.67% |
| 2013 Q2 | 25.19 Million EUR | 6.54% |
| 2013 Q3 | 17.09 Million EUR | -32.17% |
| 2013 FY | 86.64 Million EUR | -3.39% |
| 2013 Q4 | 20.7 Million EUR | 21.13% |
| 2013 Q1 | 23.65 Million EUR | 10.42% |
| 2012 Q1 | 34.12 Million EUR | -4.68% |
| 2012 Q2 | 15.93 Million EUR | -53.3% |
| 2012 Q3 | 19.53 Million EUR | 22.58% |
| 2012 Q4 | 21.42 Million EUR | 9.65% |
| 2012 FY | 89.68 Million EUR | -42.55% |
| 2011 Q2 | 46.21 Million EUR | 21.6% |
| 2011 Q4 | 35.79 Million EUR | -0.81% |
| 2011 FY | 156.11 Million EUR | 7.61% |
| 2011 Q1 | 38 Million EUR | 0.24% |
| 2011 Q3 | 36.09 Million EUR | -21.92% |
| 2010 Q1 | 34.29 Million EUR | -0.71% |
| 2010 Q3 | 36.17 Million EUR | -1.38% |
| 2010 Q4 | 37.91 Million EUR | 4.82% |
| 2010 Q2 | 36.68 Million EUR | 6.98% |
| 2010 FY | 145.06 Million EUR | 10.19% |
| 2009 Q3 | 31.36 Million EUR | -10.4% |
| 2009 FY | 131.65 Million EUR | 7.34% |
| 2009 Q4 | 34.53 Million EUR | 10.11% |
| 2009 Q2 | 35 Million EUR | 13.86% |
| 2009 Q1 | 30.74 Million EUR | 0.0% |
| 2008 FY | 122.64 Million EUR | 15.38% |
| 2007 FY | 106.29 Million EUR | 1.04% |
| 2006 FY | 105.2 Million EUR | 25.72% |
| 2005 FY | 83.68 Million EUR | 9.52% |
| 2004 FY | 76.4 Million EUR | -4.13% |
| 2003 FY | 79.69 Million EUR | 6.08% |
| 2002 FY | 75.12 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.73 Million USD | 460.614% |
| Arem Pacific Corporation | -53.66 Thousand USD | 72235.058% |
| Assisted 4 Living, Inc. | -118.27 Thousand USD | 32831.054% |
| BioCorRx Inc. | -3.76 Million USD | 1127.685% |
| Bionik Laboratories Corp. | -4.94 Million USD | 882.689% |
| Banyan Corp. | -5.48 Million USD | 806.034% |
| Clearday, Inc. | -14.3 Million USD | 370.564% |
| Dental Patient Care America, Inc. | 8974.00 USD | -431279.541% |
| Quantum Medical Transport, Inc. | 222.84 USD | -17372005.547% |
| Empower Clinics Inc. | -2826.87 USD | 1369529.793% |
| First Choice Healthcare Solutions, Inc. | -8.17 Million USD | 573.76% |
| Selectis Health, Inc. | -3.97 Million USD | 1074.872% |
| Ethema Health Corporation | 1.17 Million USD | -3190.161% |
| HealthLynked Corp. | -1.01 Million USD | 3924.529% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.78 Million USD | 1488.437% |
| JRSIS Health Care Corporation | -80.91 Thousand USD | 47944.572% |
| Comjoyful International Company | -20.62 Thousand USD | 187785.446% |
| Medical Facilities Corporation | 18.5 Million USD | -109.22% |
| MedSmart Group Inc. | -76.23 Thousand USD | 50877.161% |
| North America Frac Sand, Inc. | -798.47 Thousand USD | 4948.23% |
| Nova Leap Health Corp. | -1.05 Million USD | 3770.494% |
| Nexteligent Holdings, Inc. | -295.32 Thousand USD | 13208.226% |
| PAO Group, Inc. | 235.5 Thousand USD | -16337.658% |
| Primemd Inc. | 3.14 Million USD | -1132.78% |
| Raffles Medical Group Ltd | 68.31 Million USD | 43.331% |
| Ryman Healthcare Limited | 2.85 Million USD | -1256.404% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 914628.703% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -3.96 Million USD | 1077.315% |
| Mycotopia Therapies, Inc. | -1.18 Million USD | 3376.937% |
| U.S. NeuroSurgical Holdings, Inc. | -816 Thousand USD | 4844.118% |
| Veltex Corporation | -1.06 Million USD | 3741.546% |
| World Financial Holding Group | -28.42 Thousand USD | 136285.183% |
| Xcelerate Inc. | -2.75 Million USD | 1507.351% |